Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of health claims related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006

Lactobacillus casei, fermented milk, Clostridium difficile toxin, diarrhoea, antibiotic treatment, health claims, comments
First published in EFSA Supporting Publications
16. Juni 2011
Approved
15. Juni 2011
Type
Technical Report

Abstract

No abstract available

Contact
nda [at] efsa.europa.eu
doi
10.2903/sp.efsa.2011.EN-164
Question Number
On request from
European Commission